Eaton Vance Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Eaton Vance Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50	Closed	-$11K	–	3138
2021 Q1	$11K	Buy	+50	New	+$9.4K	﹤0.01%	2348

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Eaton Vance Management's GWPH Position: Q2 2021 in Review

Eaton Vance Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 50 shares — an estimated $11K sold.

Eaton Vance Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Eaton Vance Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Eaton Vance Management sold 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $11K.
Eaton Vance Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Eaton Vance Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.